Hesperos Inc.
PrivateLast Round
Convertible Debt
Sep 8, 2023
Total Funding Raised
$14.82M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hesperos Inc. is a biotechnology company that provides safety and efficacy testing services using its Human-on-a-Chip® platform for the pharmaceutical, cosmetic, and food industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hesperos Inc. Comparables
Compare Hesperos Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xellar Biosystems | 86% | |
| MEPSGEN | 85% | |
| Qureator | 84% |
Hesperos Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Sep 8, 2023 | ||||
| IPO | Jul 13, 2022 | ||||
| Grant | Aug 25, 2021 | ||||
| Debt | Mar 1, 2020 | ||||
| Debt | Apr 1, 2019 | ||||
Grant | Sep 6, 2018 |
Key People
Founding team and executive leadership
Hesperos Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Btomorrow Ventures | Convertible Debt |
| National Center for Advancing Translational Sciences | Grant |
| ThinkEquity | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 36% MoM, reaching 3.1K.
- Jan 20, 2026
Monthly visitors increased 50% MoM.
Hesperos Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hesperos Inc.'s valuation, stock price, and market status.
Is Hesperos Inc. a public or private company?
Hesperos Inc. is a private company.
What is the current stock price of Hesperos Inc.?
Hesperos Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Hesperos Inc. worth (valuation)?
Valuation information for Hesperos Inc. is not publicly available.
Can I buy Hesperos Inc. stock?
Hesperos Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hesperos Inc.'s last funding round?
Hesperos Inc.'s most recent funding round was Convertible Debt on September 8, 2023.
Who are the main investors in Hesperos Inc.?
Key investors in Hesperos Inc. include Btomorrow Ventures, ThinkEquity.
Will Hesperos Inc. IPO soon?
No public IPO plans have been announced for Hesperos Inc..
How can I track Hesperos Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hesperos Inc.'s secondary market activity and sign up for updates.